Dr. Dimitri Emmanuel Delagrammaticas, MD

Dr. Delagrammaticas practices at Central Coast Orthopedic Medical Group in San Luis Obispo, California.

Dr. Delagrammaticas' NPI, 1881936128, was assigned on March 25, 2013. Dr. Delagrammaticas graduated from Georgetown University School Of Medicine in 2013. Dr. Delagrammaticas holds California license A161981.

Dr. Delagrammaticas' primary practice is Central Coast Orthopedic Medical Group, at 862 Meinecke Ave, San Luis Obispo, CA 93405 in San Luis Obispo County. The practice phone is (805) 541-4600.

Dr. Delagrammaticas' primary practice is Central Coast Orthopedic Medical Group in San Luis Obispo, California. Dr. Delagrammaticas is also affiliated with Dignity Health - French Hospital Medical Center. The medical group on file is Central Coast Orthopedic Medical Group. Dmand AI also links Dr. Delagrammaticas to 2 more hospitals, 3 home health agencies, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Delagrammaticas practices, 8 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Delagrammaticas' primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Delagrammaticas is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Delagrammaticas' licenses on file in 3 states: California, Colorado and Illinois.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, broken or dislocated ankle/ or foot, bursitis, enthesopathy in arms, hip replacement, joint pain and knee arthroscopy among the conditions Dr. Delagrammaticas treats.

CMS data shows 5,173 Medicare services from Dr. Delagrammaticas across 15 procedure codes in 2024, for 871 Medicare patients. Medicare paid $351,336 for them.

CMS counts 871 Medicare patients who saw Dr. Delagrammaticas in 2024. The largest group is 65 to 74, with 428 patients. 75% of them have arthritis, and 73% have high cholesterol. 7% are also on Medicaid. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Delagrammaticas' median patient age at 72, with 61% women.

In 2024, Dr. Delagrammaticas wrote 1,485 Medicare Part D claims for 359 patients. 100% of them were for generic drugs. CMS names the drug for 1,473 of them, across 8 drugs with 11 or more claims each, at $7,220 in total drug cost. In 2023, CMS named 846 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Delagrammaticas for performance year 2024, reported as part of a group. Dr. Delagrammaticas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 180 procedures of hip replacement by Dr. Delagrammaticas, more than 99% of the clinicians it reports for that procedure.

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Delagrammaticas, published from 2015 to 2022. 2019 was the busiest year, with 4. The most frequent topics are Arthroplasty, Replacement, Hip, Acetabulum and Fluoroscopy. Dr. Delagrammaticas has published most often in Hip Int. Dr. Delagrammaticas' most frequent co-authors are David W. Manning, MD, Michael D. Stover, MD and Matthew Dean Beal, MD.

CMS Open Payments shows 109 general payments to Dr. Delagrammaticas from 12 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 54% of the total. Stryker Corporation paid the most, $5,971.

Dr. Delagrammaticas graduated from Georgetown University School Of Medicine in 2013.

Dr. Delagrammaticas is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.